Journal article · 2026 · Open access

Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder

Svenja Müller, Josef Frank, Eric Zillich, Fabian Streit, Valentin Nicolai Koch, Miriam A. Schiele, Katharina Domschke, André Tadić, David P. Herzog, Stefanie Wagner, Marianne B. Mueller, Giulia Treccani and 6 more

Molecular Psychiatry · Published 2 November 2026 · DOI 10.1038/s41380-026-03945-1

Open PDFView at the publisherCite this paper

In brief

“Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder” is a 2026 journal article by Svenja Müller and 17 co-authors, published in Molecular Psychiatry. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Molecular Psychiatry.

Citations
0
References
67
Authors
18

Abstract

Although antidepressants remain the main pharmacological treatment for major depressive disorder (MDD), therapeutic response varies, highlighting the need for molecular markers that predict treatment response, as well as insights into the biological processes underlying antidepressant efficacy. Candidate-gene and cross-sectional epigenome-wide association studies (EWAS) have reported DNA methylation signatures associated with antidepressant response; however, findings remain inconsistent. To date, no longitudinal EWAS has examined methylation trajectories across multiple time points during antidepressant treatment in MDD. Within the Early Medication Change trial, DNA methylation data was generated for 162 patients with MDD (81 responders, 81 non-responders) and 48 matched healthy controls. Patients were assessed at four times across eight-weeks of standardized antidepressant treatment, while controls were assessed twice. Differentially methylated positions (DMPs) and regions (DMRs) were identified using longitudinal EWAS models and the comb-p algorithm. Baseline methylation levels were associated with depressive symptom severity at day 28 and day 56 through two and six DMRs, respectively (e.g., TNRC6C, CAT), whereas no single DMP reached significance. Longitudinal analyses identified one DMP associated with improvement in depressive symptoms (YLMP1) and three DMRs showing methylation changes over time (e.g., GPR126, PM20D1). Combined patient-control analyses revealed additional DMPs and DMRs associated with diagnosis and temporal effects. This study provides first longitudinal evidence of regionally coordinated DNA methylation changes during antidepressant pharmacotherapy, revealing alterations in genes involved in neuroplasticity and inflammatory processes that are associated with clinical response. Replication and functional validation will be essential to determine their relevance for personalized antidepressant treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Müller, S., Frank, J., Zillich, E., Streit, F., Koch, V. N., Schiele, M. A., Domschke, K., Tadić, A., Herzog, D. P., Wagner, S., Mueller, M. B., Treccani, G., Gassen, N. C., Rietschel, M., Witt, S. H., Lieb, K., Engelmann, J., & Zillich, L. (2026). Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder. Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03945-1

MLA 9

Müller, Svenja, et al. “Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder.” Molecular Psychiatry, 2026. https://doi.org/10.1038/s41380-026-03945-1.

Chicago

Müller, Svenja, Josef Frank, Eric Zillich, Fabian Streit, Valentin Nicolai Koch, Miriam A. Schiele, Katharina Domschke, et al. 2026. “Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder.” Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03945-1.

Harvard

Müller, S. et al. (2026) ‘Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder’, Molecular Psychiatry. doi:10.1038/s41380-026-03945-1.

IEEE

S. Müller et al., “Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder,” Molecular Psychiatry, 2026, doi: 10.1038/s41380-026-03945-1.

BibTeX

@article{muller2026dynamic,
  title     = {{Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder}},
  author    = {Müller, Svenja and Frank, Josef and Zillich, Eric and Streit, Fabian and Koch, Valentin Nicolai and Schiele, Miriam A. and Domschke, Katharina and Tadić, André and Herzog, David P. and Wagner, Stefanie and Mueller, Marianne B. and Treccani, Giulia and Gassen, Nils C. and Rietschel, Marcella and Witt, Stephanie H. and Lieb, Klaus and Engelmann, Jan and Zillich, Lea},
  journal   = {Molecular Psychiatry},
  year      = {2026},
  doi       = {10.1038/s41380-026-03945-1},
  url       = {https://doi.org/10.1038/s41380-026-03945-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression

  • major depressive disorder
  • antidepressant response
  • DNA methylation
  • differentially methylated regions
  • treatment response biomarkers
  • depression severity
  • neuroplasticity
  • inflammation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Müller, S., Frank, J., Zillich, E., Streit, F., Koch, V. N., Schiele, M. A., Domschke, K., Tadić, A., Herzog, D. P., Wagner, S., Mueller, M. B., Treccani, G., Gassen, N. C., Rietschel, M., Witt, S. H., Lieb, K., Engelmann, J., & Zillich, L. (2026). Dynamic epigenetic changes during antidepressant pharmacotherapy in major depressive disorder. Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03945-1

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Psychiatry: sign in and open the PDF from this page.

Who wrote this paper?

Svenja Müller, Josef Frank, Eric Zillich, Fabian Streit, Valentin Nicolai Koch, Miriam A. Schiele, Katharina Domschke, André Tadić, David P. Herzog, Stefanie Wagner, Marianne B. Mueller, Giulia Treccani and 6 more.

What is the DOI of this paper?

10.1038/s41380-026-03945-1, permanently at https://doi.org/10.1038/s41380-026-03945-1. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.